Two Sigma Advisers’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.5M | Sell |
|
|||||
|
2025
Q1 | $90.4M | Sell |
|
|||||
|
2024
Q4 | $93.7M | Buy |
|
|||||
|
2024
Q3 | $85.8M | Buy |
|
|||||
|
2024
Q2 | $55.3M | Buy |
|
|||||
|
2024
Q1 | $46.2M | Sell |
|
|||||
|
2023
Q4 | $56.2M | Buy |
|
|||||
|
2023
Q3 | $54.3M | Buy |
|
|||||
|
2023
Q2 | $29.1M | Buy |
|
|||||
|
2023
Q1 | $11.4M | Sell |
|
|||||
|
2022
Q4 | $23.2M | Sell |
|
|||||
|
2022
Q3 | $28.5M | Sell |
|
|||||
|
2022
Q2 | $31.6M | Buy |
|
|||||
|
2022
Q1 | $15.9M | Buy |
|
|||||
|
2021
Q4 | $10.9M | Buy |
|
|||||
|
2021
Q3 | $3.51M | Buy |
|